Full Court upholds Sequenom’s win in patent battle over prenatal genetic tests

Adrian Ryan 2021-06-21 6:34 pm By Miklos Bolza | Sydney

Please login to bookmark

The Full Federal Court has upheld US biotech company Sequenom’s patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic’s argument that the patent merely described a way to extract incorporeal genetic information.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au